AMNEAL PHARMACEUTICALS, INC. (AMRX) /
The revenue of AMNEAL PHARMACEUTICALS, INC. over the past 10 years
Chart AMNEAL PHARMACEUTICALS, INC.: revenue, fiscal 2016–2025 Open the chart →AMNEAL PHARMACEUTICALS, INC. reported revenue of $3.02B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $1.02B — up 196% over 9 years. Year over year, revenue rose 8 times and fell once. The largest one-year move was in fiscal 2018: up 61%, from $1.03B to $1.66B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $3.02B |
| 2024ended Dec 31, 2024 | $2.79B |
| 2023ended Dec 31, 2023 | $2.39B |
| 2022ended Dec 31, 2022 | $2.21B |
| 2021ended Dec 31, 2021 | $2.09B |
| 2020ended Dec 31, 2020 | $1.99B |
| 2019ended Dec 31, 2019 | $1.63B |
| 2018ended Dec 31, 2018 | $1.66B |
| 2017ended Dec 31, 2017 | $1.03B |
| 2016ended Dec 31, 2016 | $1.02B |
Fiscal years as AMNEAL PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AMNEAL PHARMACEUTICALS, INC.
- The profitability of AMNEAL PHARMACEUTICALS, INC.
- The cash flow of AMNEAL PHARMACEUTICALS, INC.
- The debt of AMNEAL PHARMACEUTICALS, INC.
- All of AMNEAL PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- PPCPILGRIM’S PRIDE CORPORATION
- FAFFIRST AMERICAN FINANCIAL CORPORATION
- ACTEnact Holdings, Inc.
- LADLithia Motors, Inc.
- UBSIUNITED BANKSHARES INC/WV
Not investment advice. This page shows what AMNEAL PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.